Amylyx Pharmaceuticals (AMLX) Stock Chart & Stock Price History $5.36 +0.12 (+2.29%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$5.31 -0.05 (-0.86%) As of 04/25/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Amylyx Pharmaceuticals Stock Price Performance 5 Day Performance+26.71%1 Month Performance+40.68%3 Month Performance+48.89%6 Month Performance+0.94%Year-To-Date Performance+41.80%1 Year Performance+204.55% Receive AMLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address AMLX Stock Chart for Saturday, April, 26, 2025 AMLX Chart by TradingView Amylyx Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2025$5.24$5.36+2.29%$5.47$5.15664,842 shs$474.91 million04/24/2025$5.06$5.24+3.56%$5.28$4.99454,540 shs$464.27 million04/23/2025$4.92$5.06+2.85%$5.24$4.901.08 million shs$448.33 million04/22/2025$4.23$4.92+16.31%$4.95$4.281.94 million shs$435.92 million04/21/2025$3.98$4.23+6.28%$4.32$3.94895,375 shs$374.79 million04/18/2025$3.98$3.98$4.12$3.80724,313 shs$352.64 million04/17/2025$3.82$3.98+4.19%$4.12$3.80724,313 shs$352.64 million04/16/2025$3.88$3.82-1.55%$3.93$3.79495,459 shs$338.46 million04/15/2025$3.90$3.88-0.51%$4.01$3.81404,277 shs$343.78 million04/14/2025$3.65$3.90+6.85%$4.05$3.691.49 million shs$345.55 million Get the Latest News and Ratings for AMLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/11/2025$3.49$3.65+4.58%$3.68$3.42562,243 shs$323.40 million04/10/2025$3.49$3.49$3.54$3.30462,040 shs$309.22 million04/09/2025$3.31$3.49+5.44%$3.58$3.111.11 million shs$309.22 million04/09/2025$3.31$3.49+5.44%$3.58$3.111.11 million shs$309.22 million04/08/2025$3.46$3.31-4.34%$3.65$3.26524,964 shs$293.27 million04/08/2025$3.46$3.31-4.34%$3.65$3.26524,964 shs$293.27 million04/07/2025$3.43$3.46+0.87%$3.60$3.171.17 million shs$306.56 million04/04/2025$3.51$3.43-2.28%$3.56$3.26914,194 shs$303.91 million04/03/2025$3.78$3.51-7.14%$3.73$3.42721,334 shs$310.99 million04/02/2025$3.34$3.78+13.17%$3.83$3.23771,115 shs$334.92 million04/01/2025$3.54$3.34-5.65%$3.54$3.301.53 million shs$295.93 million03/31/2025$3.66$3.54-3.28%$3.63$3.441.06 million shs$313.65 million03/28/2025$3.87$3.66-5.43%$3.85$3.55515,392 shs$324.28 million03/27/2025$3.81$3.87+1.57%$3.93$3.65711,856 shs$342.89 million03/26/2025$3.78$3.81+0.79%$3.87$3.59432,087 shs$337.57 million03/25/2025$3.78$3.78$4.00$3.64701,137 shs$334.92 million Related Companies Vera Therapeutics Stock Chart Mesoblast Stock Chart Immunocore Stock Chart Travere Therapeutics Stock Chart Indivior Stock Chart Edgewise Therapeutics Stock Chart Ocular Therapeutix Stock Chart Calliditas Therapeutics AB (publ) Stock Chart Evotec Stock Chart Amphastar Pharmaceuticals Stock Chart Receive AMLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AMLX) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amylyx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amylyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy amlx Stock Free amlx Stock Alerts